During the past decade, John Flynn Private Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 2 clinical trials were completed, i.e. on average, 10% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 2 clinical trials were completed. i.e. 13.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Flynn Private Hospital" #1 sponsor was "BeiGene" with 5 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Agenus Inc." with 1 trials sponsored, "Allay Therapeutics, Inc." with 1 trials sponsored and "Basilea Pharmaceutica" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Flynn Private Hospital" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Calvary Mater Newcastle, Australia" with 1 trials as a collaborator, "Cancer Society of New Zealand" with 1 trials as a collaborator, "Caris Life Sciences" with 1 trials as a collaborator and "Health Research Council, New Zealand" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "John Flynn Private Hospital" are "B-cell Malignancies" (2 trials), "Prostatic Neoplasms" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Acute Postoperative Pain" (1 trials) and "Advanced Malignancies" (1 trials). Many other conditions were trialed in "John Flynn Private Hospital" in a lesser frequency.

Most popular intervention types in "John Flynn Private Hospital" are "Drug" (17 trials), "Biological" (4 trials), "Device" (2 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (4 trials), "Placebo" (3 trials), "Zanubrutinib" (3 trials), "BGB-11417" (2 trials) and "Prednisone" (2 trials). Other intervention names were less common.

The vast majority of trials in "John Flynn Private Hospital" are 18 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are 11 active trials in "John Flynn Private Hospital". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 7 completed trials in John Flynn Private Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in John Flynn Private Hospital, 8 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".